Results 91 to 100 of about 518 (150)

Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy. [PDF]

Front Pharmacol, 2022
Zhou X, Lian H, Li H, Fan M, Xu W, Jin Y.   +5 more
europepmc   +1 more source

Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model. [PDF]

Commun Med (Lond)
Renner TM, Stuible M, Rossotti MA, Rohani N, Cepero-Donates Y, Sauvageau J, Deschatelets L, Dudani R, Harrison BA, Baardsnes J, Koyuturk I, St Michael F, Hill JJ, Hemraz UD, Lenferink AEG, Tanha J, Fernandes B, Roldao A, McCluskie MJ, Akache B, Durocher Y.   +20 more
europepmc   +1 more source

Recent Advances in Understanding Bio-Compounds from Haloarchaea. [PDF]

J Microbiol Biotechnol
Hwang CY, Seo MJ.
europepmc   +1 more source

Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer. [PDF]

Sci Rep, 2020
Karimi H, Soleimanjahi H, Abdoli A, Banijamali RS.   +3 more
europepmc   +1 more source

Non-Polar Lipids as Regulators of Membrane Properties in Archaeal Lipid Bilayer Mimics. [PDF]

Int J Mol Sci, 2021
Salvador-Castell M, Brooks NJ, Winter R, Peters J, Oger PM.   +4 more
europepmc   +1 more source

How could the translation of nanotechnology-based therapies revolutionize cutaneous leishmaniasis treatments? [PDF]

Nanomedicine (Lond)
Di Meglio M, Maza Vega D, Montanari J.
europepmc   +1 more source

The Cell Membrane of Sulfolobus spp.-Homeoviscous Adaption and Biotechnological Applications. [PDF]

Int J Mol Sci, 2020
Rastädter K, Wurm DJ, Spadiut O, Quehenberger J.   +3 more
europepmc   +1 more source

Special Issue: Novel Vaccines and Vaccine Technologies for Emerging Infections. [PDF]

Vaccines (Basel)
Chen W, Li X, Kamen AA.
europepmc   +1 more source

PEGylated liposomes enhance the effect of cytotoxic drug: A review. [PDF]

Heliyon, 2023
Taher M, Susanti D, Haris MS, Rushdan AA, Widodo RT, Syukri Y, Khotib J.   +6 more
europepmc   +1 more source

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern. [PDF]

NPJ Vaccines, 2022
Akache B, Renner TM, Stuible M, Rohani N, Cepero-Donates Y, Deschatelets L, Dudani R, Harrison BA, Gervais C, Hill JJ, Hemraz UD, Lam E, Régnier S, Lenferink AEG, Durocher Y, McCluskie MJ.   +15 more
europepmc   +1 more source